Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mami TACHIBANA"'
Autor:
Takashi WADA, Yuki KITSUDA, Mari OSAKI, Kenjiro NARUSE, Miho MATSUBARA, Megumi ASHIKAWA, Kikue MATSUSHIGE, Naoya MATSUMOTO, Mami TACHIBANA, Yoshimasa SUZUKI, Hiroshi HAGINO
Publikováno v:
Rigakuryoho Kagaku. 37:229-235
Autor:
Reo Maruyama, Hiroaki Takahashi, Hiroyuki Yamamoto, Keisuke Ishigami, Hiroyoshi Kurihara, Yasutaka Sukawa, Kohzoh Imai, Yasuhisa Shinomura, Miki Ito, Kei Mitsuhashi, Mami Tachibana, Itaru Yamamoto, Hiromu Suzuki, Hisayoshi Igarashi, Takashi Tokino, Shinichi Kanno, Katsuhiko Nosho
Publikováno v:
Oncotarget
// Kei Mitsuhashi 1, * , Itaru Yamamoto 1, * , Hiroyoshi Kurihara 1, * , Shinichi Kanno 1, * , Miki Ito 1 , Hisayoshi Igarashi 1 , Keisuke Ishigami 1 , Yasutaka Sukawa 1, 2 , Mami Tachibana 1 , Hiroaki Takahashi 3 , Takashi Tokino 4 , Reo Maruyama 5
Autor:
Yasuhisa Shinomura, Shinichi Kanno, Koichi Hirata, Reo Maruyama, Mami Tachibana, Hisayoshi Igarashi, Hiroyuki Yamamoto, Hiroaki Takahashi, Taiga Takahashi, Tadashi Hasegawa, Miki Ito, Kei Mitsuhashi, Yasutaka Sukawa, Hiroyoshi Kurihara, Hiromu Suzuki, Toshinao Takenouchi, Shinji Yoshii, Katsuhiko Nosho, Kenji Okita, Kohzoh Imai
Publikováno v:
International Journal of Cancer. 137:1258-1268
Human gut microbiota is being increasingly recognized as a player in colorectal cancers (CRCs). Evidence suggests that Fusobacterium nucleatum (F. nucleatum) may contribute to disease progression and is associated with CpG island methylator phenotype
Autor:
Reo Maruyama, Hiromu Suzuki, Yasuhisa Shinomura, Hiroyuki Yamamoto, Miki Ito, Tadashi Hasegawa, Masafumi Imamura, Shinichi Kanno, Koichi Hirata, Yasushi Adachi, Katsuhiko Nosho, Yasutaka Matsunaga, Kei Mitsuhashi, Tokuma Tanuma, Takafumi Naito, Hiroyuki Maguchi, Mami Tachibana, Hisayoshi Igarashi, Hiroyoshi Kurihara, Yasutaka Sukawa, Kohzoh Imai, Yasutoshi Kimura, Toshiya Shinohara
Publikováno v:
Oncotarget
Recently, bacterial infection causing periodontal disease has attracted considerable attention as a risk factor for pancreatic cancer. Fusobacterium species is an oral bacterial group of the human microbiome. Some evidence suggests that Fusobacterium
Autor:
Tatsuo Takahashi, Yusuke Tonami, Masaaki Nomura, Tsutomu Shimada, Mami Tachibana, Shinjiro Kobayashi, Masaki Aburada
Publikováno v:
Biological & Pharmaceutical Bulletin = Biological & Pharmaceutical Bulletin. 35(10):1765-1774
One of the mediators of osteoclast differentiation is receptor activator of nuclear factor κB ligand (RANKL), which is produced by osteoblasts. Binding of RANKL to its receptor, RANK, activates several signaling pathways, including those involving m
Autor:
Miki, Ito, Shinichi, Kanno, Katsuhiko, Nosho, Yasutaka, Sukawa, Kei, Mitsuhashi, Hiroyoshi, Kurihara, Hisayoshi, Igarashi, Taiga, Takahashi, Mami, Tachibana, Hiroaki, Takahashi, Shinji, Yoshii, Toshinao, Takenouchi, Tadashi, Hasegawa, Kenji, Okita, Koichi, Hirata, Reo, Maruyama, Hiromu, Suzuki, Kohzoh, Imai, Hiroyuki, Yamamoto, Yasuhisa, Shinomura
Publikováno v:
International journal of cancer. 137(6)
Human gut microbiota is being increasingly recognized as a player in colorectal cancers (CRCs). Evidence suggests that Fusobacterium nucleatum (F. nucleatum) may contribute to disease progression and is associated with CpG island methylator phenotype
Autor:
Shinichi Kanno, Yasuhisa Shinomura, Hiroyuki Yamamoto, Yasutaka Sukawa, Hiroyoshi Kurihara, Hisayoshi Igarashi, Kei Mitsuhashi, Hiromu Suzuki, Kohzoh Imai, Shinji Yoshii, Katsuhiko Nosho, Mami Tachibana, Miki Ito
Publikováno v:
Gastroenterology. 148:S-576